Floatz logo

249 assets in Head And Neck Squamous Cell Carcinoma

Therapeutic assets addressing Head And Neck Squamous Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
ab598
Head And Neck Squamous Cell Carcinoma
Arcus Biosciences, Inc.P1CC (43)
Abbv-400
Head And Neck Squamous Cell Carcinoma
AbbVieP1CC (43)
Anti-Egfr Antibody-Drug Conjugate Mrg003
Head And Neck Squamous Cell Carcinoma
Sun Yat-sen UniversityP1CC (43)
Bbi-355
Head And Neck Squamous Cell Carcinoma
Boundless Bio, Inc.P1CC (43)
Bbi-825
Head And Neck Squamous Cell Carcinoma
Boundless Bio, Inc.P1CC (43)
bi 770371
Head And Neck Squamous Cell Carcinoma
Boehringer IngelheimP1CC (43)
Bl-B16D1
Head And Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P1CC (43)
Capivasertib
Head And Neck Squamous Cell Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Epi-326
Head And Neck Squamous Cell Carcinoma
EpiBiologicsP1CC (43)
exs74539
Head And Neck Squamous Cell Carcinoma
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1CC (43)
Futibatinib
Head And Neck Squamous Cell Carcinoma
Boundless Bio, Inc.P1CC (43)
imm2520
Head And Neck Squamous Cell Carcinoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1CC (43)
Immunoglobulin G1 [301-Alanine,De-C-Terminal-Lysine], Anti-(Human Cd73 Antigen) (Human-Mus Musculus Monoclonal Inca00186 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Inca00186 ?-Chain, Dimer
Head And Neck Squamous Cell Carcinoma
Incyte CorporationP1CC (43)
Ipn 60090
Head And Neck Squamous Cell Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Itraconazole
Head And Neck Squamous Cell Carcinoma
AbbVieP1CC (43)
Janx008
Head And Neck Squamous Cell Carcinoma
Janux TherapeuticsP1CC (43)
LY3143921
Head And Neck Squamous Cell Carcinoma
Cancer Research UKP1CC (43)
pf-07265028
Head And Neck Squamous Cell Carcinoma
PfizerP1CC (43)
pf-07820435
Head And Neck Squamous Cell Carcinoma
PfizerP1CC (43)
pf-07826390
Head And Neck Squamous Cell Carcinoma
PfizerP1CC (43)
pf-08046037
Head And Neck Squamous Cell Carcinoma
PfizerP1CC (43)
pf-08046052
Head And Neck Squamous Cell Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1CC (43)
pf-08046054
Head And Neck Squamous Cell Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1CC (43)
pf-08046876
Head And Neck Squamous Cell Carcinoma
PfizerP1CC (43)
Rndo-564
Head And Neck Squamous Cell Carcinoma
Rondo TherapeuticsP1CC (43)
sh009
Head And Neck Squamous Cell Carcinoma
Nanjing Sanhome Pharmaceutical, Co., Ltd.P1CC (43)
Slv-154
Head And Neck Squamous Cell Carcinoma
Solve TherapeuticsP1CC (43)
Sonidegib
Head And Neck Squamous Cell Carcinoma
Mayo ClinicP1CC (43)
Stro-004
Head And Neck Squamous Cell Carcinoma
Sutro Biopharma, Inc.P1CC (43)
Vrp-Encapsulated Sarna Encoding Il-12
Head And Neck Squamous Cell Carcinoma
VLP TherapeuticsP1CC (43)
xb010
Head And Neck Squamous Cell Carcinoma
ExelixisP1CC (43)
Nogapendekin Alfa Inbakicept
Head And Neck Squamous Cell Carcinoma
ImmunityBio, Inc.P2CC (42)
[111in]-fpi-1967
Head And Neck Squamous Cell Carcinoma
Fusion Pharmaceuticals Inc.P1/2CC (41)
[111in]-fpi-2058
Head And Neck Squamous Cell Carcinoma
3B Pharmaceuticals GmbHP1CC (41)
[225Ac]-FPI-1966
Head And Neck Squamous Cell Carcinoma
Fusion Pharmaceuticals Inc.P1/2CC (41)
[225]-fpi-2059
Head And Neck Squamous Cell Carcinoma
3B Pharmaceuticals GmbHP1CC (41)
Ale.P02
Head And Neck Squamous Cell Carcinoma
Alentis Therapeutics AGP1/2CC (41)
alx2004
Head And Neck Squamous Cell Carcinoma
ALX Oncology Inc.P1CC (41)
Amt-116 Car-T Cells
Head And Neck Squamous Cell Carcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd.P1/2CC (41)
Amt-253 Car-T Cells
Head And Neck Squamous Cell Carcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd.P1/2CC (41)
azd6750
Head And Neck Squamous Cell Carcinoma
AstraZenecaP1/2CC (41)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)-
Head And Neck Squamous Cell Carcinoma
VM Oncology, LLCP1/2CC (41)
dm005
Head And Neck Squamous Cell Carcinoma
Doma Biopharmaceutical（Suzhou）Co., Ltd.P1CC (41)
Dp Cd8 Til
Head And Neck Squamous Cell Carcinoma
AgonOx, Inc.P1CC (41)
Fruquintinib
Head And Neck Squamous Cell Carcinoma
Immunitas TherapeuticsP1/2CC (41)
Hafnium Oxide
Head And Neck Squamous Cell Carcinoma
NanobiotixP1CC (41)
hc-7366
Head And Neck Squamous Cell Carcinoma
HiberCell, Inc.P1CC (41)
H-Gamma1 Heavy Chain Humanized (1-449) [Vh (Homo Sapiens Ighv3-23*01 (81.6%) -(Ighd) -Ighj3*02 (91.7%) M123>T (114), Cdr-Imgt [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo Sapiens Ighg1*03V (100%) G1M3>G1M17, Ng1M1 Ch1 K120, Ch3 E12, M14 (Ch1 R120>K (216) (120-217), Hinge 1-15 (218-232), Ch2 (233-342), Ch3 E12 (358), M14 (360) (343-447), Chs (448-449)) (120-449)], (222-218')-Disulfide With L-Kappa Light Chain Humanized (1'-218') [Vkappa (Homo Sapiens Igkv1-33*01 (87.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.13] (27'-32'.50'-52'.89'-101')) (1'-111')-Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (C-Kappaa45.1 (157'), V101 (195')) (112'-218')]; Dimer (228-228'':231-231'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa
Head And Neck Squamous Cell Carcinoma
Genentech, Inc.P1CC (41)
Humanized Immunoglobulin G1-Kappa Anti-(Human Cd8) Fused At The C-Terminus Of One Heavy Chain, Via Peptide Linker <Sup>449</Sup> Sggggsggggsggggs<Sup>464</Sup>, To A Variant Of Human Interleukin-2, Glycoform Alfa
Head And Neck Squamous Cell Carcinoma
Asher Biotherapeutics, Inc.P1CC (41)
Idp-001
Head And Neck Squamous Cell Carcinoma
InduPro, Inc.P1/2CC (41)
Showing 101 to 150 of 249 assets
PreviousPage 3 of 5Next